Gene · 9775
Papers1,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EIF4A3-negatively driven circular RNA β-catenin (circβ-catenin) promotes colorectal cancer progression via miR-197-3p/CTNND1 regulatory axis. | Br J Cancer | 2024 | 38459187 | PubTator, text mining | PubMed |
| A unique circ_0067716/EIF4A3 double-negative feedback loop impacts malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene. | Sci Total Environ | 2024 | 38438030 | PubTator, text mining | PubMed |
| Differential alternative splicing landscape identifies potentially functional RNA binding proteins in early embryonic development in mammals. | iScience | 2024 | 38433915 | PubTator, text mining | PubMed |
| Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3. | BMC Cancer | 2024 | 38383334 | PubTator, text mining | PubMed |
| LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated β-catenin mRNA nuclear exportation. | Environ Toxicol | 2024 | 38317508 | PubTator, text mining | PubMed |
| Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers. | Clin Exp Med | 2024 | 38294554 | PubTator, text mining | PubMed |
| Understanding YTHDF2-mediated mRNA Degradation By m6A-BERT-Deg. | ArXiv | 2024 | 38292306 | PubTator, text mining | PubMed |
| Splicing inhibition mediated by reduced splicing factors and helicases is associated with the cellular response of lung cancer cells to cisplatin. | Comput Struct Biotechnol J | 2024 | 38283853 | PubTator, text mining | PubMed |
| MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation. | J Exp Clin Cancer Res | 2024 | 38268030 | PubTator, text mining | PubMed |
| Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc. | J Oncol | 2024 | 38249992 | PubTator, text mining | PubMed |
| The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. | Cancer Cell Int | 2024 | 38238756 | PubTator, text mining | PubMed |
| Multi-omic analyses of m5C readers reveal their characteristics and immunotherapeutic proficiency. | Sci Rep | 2024 | 38238581 | PubTator, text mining | PubMed |
| A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer. | Proc Natl Acad Sci U S A | 2024 | 38232291 | PubTator, text mining | PubMed |
| Retracted: Molecular Mechanism of 73HOXC-AS1-Activated Wntβ-Catenin Signaling and eIF4AIII in Promoting Progression of Gastric Cancer. | Biomed Res Int | 2024 | 38230028 | PubTator, text mining | PubMed |
| EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance. | J Exp Clin Cancer Res | 2024 | 38163881 | PubTator, text mining | PubMed |
| circNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis. | Eur J Pharmacol | 2024 | 38128869 | PubTator, text mining | PubMed |
| lncRNA799/TBL1XR1/ZEB1 Axis Forms a Feedback Loop to Promote the Epithelial-Mesenchymal Transition of Cervical Cancer Cells. | Crit Rev Eukaryot Gene Expr | 2024 | 38073440 | PubTator, text mining | PubMed |
Circ ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 increases the stability of G9a and ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 messenger RNA through recruiting eukaryotic translation initiation factor 4A3, transcriptionally inhibiting PDZ and homeobox protein domain protein 1, and promotes the metastasis of hepatocellular carcinoma. | J Gastroenterol Hepatol | 2024 | 38059880 | PubTator, text mining | PubMed |
| M6A reader YTHDF1 promotes malignant progression of laryngeal squamous carcinoma through activating the EMT pathway by EIF4A3. | Cell Signal | 2024 | 38048860 | PubTator, text mining | PubMed |
| The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia. | Leukemia | 2024 | 38036629 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9775/papers?page=9